BLUEBIRD BIO INC (BLUE)
US09609G1004 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -91.17M | -266.58M | -819.38M | -618.70M | -789.61M | |||
| Depreciation Amortization | 4.37M | 5.00M | 19.65M | 19.36M | 17.43M | |||
| Change In Working Capital | -22.82M | -39.12M | 17.99M | -28.85M | 46.12M | |||
| Interest Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 250.00K | 620.00K | 360.00K | 640.00K | |||
| Other non cash items | -167.87M | -52.25M | 146.11M | 157.84M | 161.67M | |||
| OPERATING CASH FLOW | -277.48M | -352.95M | -635.64M | -470.35M | -564.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -8.95M | -13.21M | -23.00M | -28.99M | -76.25M | |||
| Other Investing Activity | 263.36M | 263.66M | 585.56M | -55.36M | 584.06M | |||
| INVESTING CASH FLOW | 254.40M | 250.45M | 562.56M | -84.35M | 507.81M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 129.85M | 54.25M | 80.33M | 546.72M | 21.19M | |||
| Other Financing Activity | N/A | 0.00 | -174.28M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 129.85M | 54.25M | -93.95M | 546.72M | 21.19M | |||
| CHANGE IN CASH | 106.77M | -48.25M | -167.03M | -7.98M | -35.38M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -277.48M | -352.95M | -635.64M | -470.35M | -564.38M | |||
| Capital Expenditure | -8.95M | -13.21M | -23.00M | -28.99M | -76.25M | |||
| FREE CASH FLOW | -286.43M | -366.16M | -658.64M | -499.34M | -640.63M | |||
All data in USD